SanBio Co Ltd (SNBIF)
3.85
0.00 (0.00%)
USD |
OTCM |
Jun 14, 16:00
SanBio Net Income (Quarterly): -0.9592M for April 30, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| April 30, 2024 | -0.9592M |
| January 31, 2024 | -5.200M |
| October 31, 2023 | -0.6482M |
| July 31, 2023 | -8.304M |
| April 30, 2023 | -4.698M |
| January 31, 2023 | -28.10M |
| October 31, 2022 | 2.805M |
| July 31, 2022 | -13.83M |
| April 30, 2022 | -2.637M |
| January 31, 2022 | -13.68M |
| October 31, 2021 | -8.840M |
| July 31, 2021 | -11.59M |
| April 30, 2021 | -7.983M |
| January 31, 2021 | 14.01M |
| October 31, 2020 | -15.47M |
| July 31, 2020 | -15.85M |
| April 30, 2020 | -13.90M |
| January 31, 2020 | -17.20M |
| October 31, 2019 | -11.49M |
| Date | Value |
|---|---|
| July 31, 2019 | -12.07M |
| April 30, 2019 | -6.63M |
| January 31, 2019 | -12.30M |
| October 31, 2018 | -4.536M |
| July 31, 2018 | -1.850M |
| April 30, 2018 | -7.814M |
| January 31, 2018 | -6.958M |
| October 31, 2017 | -7.935M |
| July 31, 2017 | -10.54M |
| April 30, 2017 | -9.789M |
| January 31, 2017 | -1.268M |
| October 31, 2016 | -5.344M |
| July 31, 2016 | -8.174M |
| April 30, 2016 | -2.464M |
| January 31, 2016 | -4.283M |
| October 31, 2015 | -0.2543M |
| July 31, 2015 | -2.699M |
| April 30, 2015 | -0.9125M |
| January 31, 2015 | -1.505M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-28.10M
Minimum
Jan 2023
14.01M
Maximum
Jan 2021
-8.782M
Average
-10.16M
Median
Net Income (Quarterly) Benchmarks
| Takeda Pharmaceutical Co Ltd | -20.33M |
| Nxera Pharma Co Ltd | -22.11M |
| PeptiDream Inc | -5.677M |
| Healios KK | -16.33M |
| AnGes Inc | -12.29M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 4.414M |
| EPS Diluted (Quarterly) | -0.014 |
| Enterprise Value | 242.73M |
| Earnings Yield | -5.99% |
| Normalized Earnings Yield | -24.04 |